title: Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis.
abstract: Between April 1981 and July 1984, 51 patients received intraoperative radiation therapy (IORT) as a component of therapy for the management of primary or recurrent pelvic malignancies which were initially unresectable for cure. For these patients, curative surgical alternatives did not exist, or would have involved extensive procedures such as pelvic exenteration, distal sacrectomy, hemipelvectomy, or hemicorporectomy. The primary disease was colorectal in 38 patients. Treatment consisted of external beam radiation (range 3000 to 6890 cGy, median 5040 cGy), surgical debulking when feasible, and an intraoperative electron beam boost to the gross or microscopic residual disease (dose range 1000 to 2500 cGy, median 1750 cGy) utilizing 9-18 MeV electrons. The most common IORT associated toxicities were peripheral neuropathy and ureteral obstruction. None were life-threatening or fatal in severity. Of the 50 patients evaluable for neurotoxicity analysis, 16 (32%) developed peripheral neuropathy consisting of pain in 16 patients, numbness and tingling in 11, and weakness in 8. The pain, numbness and tingling resolved in about 40% of patients, while weakness resolved in only 1 of 8. Sixteen ureters were initially unobstructed by tumor at the time of IORT. Of these, 10 (63%) subsequently showed evidence of obstruction and hydronephrosis. The development of neurotoxicity was more common at IORT doses of 1500 cGy or more versus 1000 cGy. Ureteral obstruction with hydronephrosis occurred more frequently at IORT doses of 1250 cGy or more compared to 1000 cGy. There was no relationship between the likelihood of developing complications and the total external beam dose. The observed dependence of human nerve toxicity primarily on the IORT dose is consistent with data generated from animal experiments.
authors.affiliation: Division of Radiation Oncology, Mayo Clinic, Rochester, Minesota.
authors.forename: E G
authors.initials: EG
authors.lastname: Shaw
authors.forename: L L
authors.initials: LL
authors.lastname: Gunderson
authors.forename: J K
authors.initials: JK
authors.lastname: Martin
authors.forename: R W
authors.initials: RW
authors.lastname: Beart
authors.forename: D M
authors.initials: DM
authors.lastname: Nagorney
authors.forename: K C
authors.initials: KC
authors.lastname: Podratz
mesh_terms: D015179:Colorectal Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006801:Humans; D007430:Intraoperative Care; D008297:Male; D008875:Middle Aged; D010386:Pelvic Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D010525:Peripheral Nerves / Q000528:radiation effects*; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D011836:Radiation Tolerance; D011882:Radiotherapy, High-Energy / Q000009:adverse effects*; D014513:Ureter / Q000528:radiation effects*; D014517:Ureteral Obstruction / Q000209:etiology